Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 2.000
+0.250 (14.29%)
Jul 31, 2026, 4:08 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 2.6 billion as of July 31, 2026. Its market cap has increased by 239.24% in one year.
Market Cap
2.60B
Enterprise Value
2.29B
Revenue
3.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
ChartMarket Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 2.60B, a decrease of -82.73%. That is a compound annual growth rate of -30.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.60B | -14.52% |
| Dec 31, 2025 | 3.04B | 871.54% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.19B |
| Jiangsu Recbio Technology | 3.10B |
| HJ Science | 2.98B |
| Shandong Boan Biotechnology | 2.92B |
| Beijing Luzhu Biotechnology | 2.78B |
| Viva Biotech Holdings | 2.70B |
| Antengene Corporation | 2.68B |
| TYK Medicines | 2.62B |